1 strip - 10 tablets · Marketed by Torrent Pharmaceuticals Ltd
Composition: Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
A FirstCare pharmacist checks your prescription before this is sent.
₹26.25 / tablet
Inclusive of all taxes
Sold and delivered by FirstCare Pharmacy
Trivoglitor 2 Tablet SR helps control high blood glucose levels after meals and supports better overall diabetes management. The medicine lowers the risk of serious complications of diabetes, such as kidney damage, vision problems, nerve issues, and limb loss. It also helps reduce the risk of death from cardiovascular disease in people with type 2 diabetes who already have heart disease. Regular use of Trivoglitor 2 Tablet SR, along with a healthy diet and exercise, supports long-term health and helps you maintain a more stable and active life.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Trivoglitor 2 Tablet SR is to be taken on an empty stomach.
Trivoglitor 2 Tablet SR is a combination of three antidiabetic medicines: glimepiride, metformin, and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea that works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide that lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor that prevents the breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.
Alcohol
It is unsafe to consume alcohol with Trivoglitor 2 Tablet SR
Pregnancy
The safety of Trivoglitor 2 Tablet SR during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
Breastfeeding
Trivoglitor 2 Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
It is not known whether Trivoglitor 2 Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
Kidney
Trivoglitor 2 Tablet SR is unsafe to use in patients with kidney disease and should be avoided.
Use of Trivoglitor 2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Liver
Trivoglitor 2 Tablet SR is unsafe to use in patients with liver disease and should be avoided.
Trivoglitor 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Store below 25°C
This information is for reference only. Use medicines only as your doctor advises.
Same composition and strength, cheapest first.